KCM
GSK icon

Key Capital Management’s GSK GSK Stock Holding History

Key Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Sell
412
-548
-57% -$29K 0.01% 243
2026
Q1 		$53K Buy
960
+653
+213% +$35.4K 0.04% 146
2025
Q4 		$15.1K Buy
+307
New +$14.3K 0.01% 239

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Key Capital Management's GSK Position: Q2 2026 in Review

Key Capital Management reduced its GSK (GSK) stake by 57% in Q2 2026, selling an estimated $29K and leaving 412 shares worth $21.6K. The position accounts for 0.01% of the portfolio, ranked #243.

Key Capital Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $53K in Q1 2026. 578 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Key Capital Management held 412 shares of GSK worth $21.6K as of Q2 2026.
  • Key Capital Management sold 548 GSK shares in Q2 2026, an estimated $29K.
  • GSK made up 0.01% of Key Capital Management's portfolio in Q2 2026, its #243 holding.
  • Key Capital Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Key Capital Management's GSK position peaked at $53K in Q1 2026.
  • 578 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.